Skip to main content
. 2022 Jan 24;20(1):e07031. doi: 10.2903/j.efsa.2022.7031

Table A.4 Outline of the appraisal questions for field effect experiments with bees

Section Acronym Question
External validity Q1_EV How confident are we that the assessment endpoint can be used to inform the risk assessment of bees?
Q2_EV Are the test organisms exposed to either flupyradifurone or acetamiprid in isolation (without any other active substances)?
Q3_EV Are the tested organisms relevant for Europe?
Q4_EV Is the study location representative of any EU biogeographical region?
Q5_EV Is the study setting representative of an EU agricultural landscape?
Q6_EV Do the experimental conditions represent a reasonable worst‐case for both exposure and possible triggering of the effects?
Internal validity Q1_IV Is the origin of the tested organism trustable?
Q2_IV

Were the test organisms properly acclimatised to the study setup before the exposure started?

Q3_IV Are the test organisms healthy and stress‐free at the start of the experiment?
Q4_IV Is the methodology used (including the experimental setup) for measuring the assessment endpoint reliable?
Q5_IV Is the negative control free from contamination and performing adequately?
Q6_IV Are the treatments and exposure levels well characterised?
Q7_IV Is the test item clearly identified and characterised?
Q8_IV Is the duration of the test appropriate to characterise the assessment endpoint?
Q9_IV Is the presence of other stressors checked and accounted for?
Q10_IV Is the derivation of the measured endpoint(s) performed with sound statistical methods?
Precision Q1_PR Are the sample size and replication appropriate?